Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

WATSON LABS TEVA

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 28
  • 0 comments

FDA approve ALVIMOPAN

Comment Full text

CAPLIN

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 29
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

CUBIST PHARMS

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 29
  • 0 comments

FDA approve ALVIMOPAN

Comment Full text

LUPIN LTD

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 35
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

ASPIRO

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 29
  • 0 comments

FDA approve SUGAMMADEX SODIUM

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 34
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

LANNETT CO INC

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 32
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

DR REDDYS

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 38
  • 0 comments

FDA approve PREGABALIN

Comment Full text

ALEMBIC

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 30
  • 0 comments

FDA approve PREGABALIN

Comment Full text

UNICHEM

  • FDA Approval
  • June 13, 2023, 11:39 UTC
  • 37
  • 0 comments

FDA approve DIVALPROEX SODIUM

Comment Full text
  • Previous
  • 787
  • 788
  • 789
  • 790
  • 791
  • Next

Search

News categories

  • Technical Exchange News(12095)
  • Event(5387)
  • SEC News(252326)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150691)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin